References
Ohmachi K, Niitsu N, Uchida T, Kim SJ, Ando K, Takahashi N, Takahashi N, Uike N, Eom HS, Chae YS, Terauchi T, Tateishi U, Tatsumi M, Kim WS, Tobinai K, Suh C, Ogura M (2013) Multicenter phase II study of bendamustine plus rituximab in patients with relapsed or refractory diffuse large B-cell lymphoma. J Clin Oncol 31:2103–2109
Hosoda T, Yokoyama A, Yoneda M, Yamamoto R, Ohashi K, Kagoo T, Ueno H, Boku S, Yano T (2013) Bendamustine can severely impair T-cell immunity against cytomegalovirus. Leuk Lymphoma. 54:1327–1328
Hasegawa T, Aisa Y, Shimazaki K, Nakazato T (2015) Cytomegalovirus reactivation with bendamustine in patients with low-grade B-cell lymphoma. Ann Hematol 94:515–517
Isono N, Imai Y, Watanabe A, Moriya K, Tamura H, Inokuchi K, Asano C, Masuda M, Shimura H, Mitsuhashi K, Kazama H, Sugimori H, Motoji T, Tanaka J (2016) Cytomegalovirus reactivation in low-grade B-cell lymphoma patients treated with bendamustine. Leuk Lymphoma 57:2204–2207
Saito H, Maruyama D, Maeshima AM, Makita S, Kitahara H, Miyamoto K, Fukuhara S, Munakata W, Suzuki T, Kobayashi Y, Taniguchi H, Tobinai K (2015) Prolonged lymphocytopenia after bendamustine therapy in patients with relapsed or refractory indolent B-cell and mantle cell lymphoma. Blood Cancer J 5:e362
Ford N, Shubber Z, Saranchuk P, Pathai S, Durier N, O’Brien DP et al (2013) Burden of HIV-related cytomegalovirus retinitis in resource-limited settings: a systematic review. Clin Infect Dis Off Publ Infect Dis Soc Am 57:1351–1361
Acknowledgements
We thank the patients and clinical staff for their participation in the study. The authors also acknowledge the Clinical Research Institute, Kyushu Medical Hospital for editorial support.
Author information
Authors and Affiliations
Contributions
SY contributed to the study design, data analysis, and manuscript preparation; KK, MK, KT, and HI collected clinical data and reviewed the manuscript. All the authors approved the final manuscript.
Corresponding author
Ethics declarations
The study protocol was approved by the local ethics committee and institutional review board.
Conflict of interest
The authors declare that there are no competing financial interests regarding this article. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Rights and permissions
About this article
Cite this article
Yamasaki, S., Kohno, K., Kadowaki, M. et al. Cytomegalovirus retinitis in relapsed or refractory low-grade B cell lymphoma patients treated with bendamustine. Ann Hematol 96, 1215–1217 (2017). https://doi.org/10.1007/s00277-017-3005-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-017-3005-y